Photo from academic.microsoft.com
Sir, I read with great interest the Risch’s paper [1] on the urgent need to discuss COVID-19 outpatient treatment. Many strategies have been tested since the pandemic began, but all… Click to show full abstract
Sir, I read with great interest the Risch’s paper [1] on the urgent need to discuss COVID-19 outpatient treatment. Many strategies have been tested since the pandemic began, but all that has emerged regarding non-hospitalized patients is a sort of therapeutic nihilism. As I write (November 17, 2020), in Italy (60,244,639 inhabitants) there are 33,074 persons hospitalized for COVID-19, 3,612 requiring intensive-care, and many more (697,124) are in home isolation: our health-care system is on the verge of a new unsustainable burden. Most infected people are asymptomatic, but many will worsen and require hospitalization. It is therefore crucial to interrupt as early as possible disease progression. Outpatients do not receive regular laboratory monitoring, so the global disease impact on them remains unknown: any consideration on appropriate treatments must take into account this missing data. OR IG IN AL U NE DI TE D MA NU SC RI PT
Journal Title: American Journal of Epidemiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!